Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs standard-dose arterial heparin for transradial coronary angiography
IRCT201508174497N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of heparin in atherosclerosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Vascular complications after transradial coronary angiography. Started Jan 2015; status: completed.
02
Drugs
heparin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on IRCT201508174497N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201508174497N2.